Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection

PURPOSE: Acinetobacter baumannii (A. baumannii) has emerged as a major cause of nosocomial pneumonia and sepsis in seriously ill patients. Multidrug-resistant A. baumannii (MDRAB) is increasing in frequency, and the management of it's infections is consequently difficult. Therefore, tigecycline...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jung Ar, Chang, Yoon Soo, Kim, Hyung Jung, Kim, Se Kyu, Chang, Joon, Ahn, Chul Min, Byun, Min Kwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423844/
https://www.ncbi.nlm.nih.gov/pubmed/22869481
http://dx.doi.org/10.3349/ymj.2012.53.5.974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423844/
https://www.ncbi.nlm.nih.gov/pubmed/22869481
http://dx.doi.org/10.3349/ymj.2012.53.5.974

Ejemplares similares